Jianjun Zhang, MD
M.D. Anderson Cancer Center · RenJi Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jianjun Zhang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07038915 · STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1M.D. Anderson Cancer Center · withdrawn · Lung Squamous Cell Carcinoma, Anti-PD1/PDL1 Antibody · principal investigator
- Ph4NCT06353126 · DEB-TACE Prior to Liver Transplantation in the Treatment of HCCRenJi Hospital · recruiting · Liver Cancer · principal investigator
- N/ANCT06069037 · SALT for Treatment of Patients With Early ACLFRenJi Hospital · unknown · Acute-On-Chronic Liver Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.